Dose the incretin related-drug have an influence on the onset mechanism of apical periodontitis and marginal periodontitis?
Project/Area Number |
25462964
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Conservative dentistry
|
Research Institution | Kagoshima University |
Principal Investigator |
SAKUTA Tetsuya 鹿児島大学, 医歯学域附属病院, 助教 (20284888)
|
Project Period (FY) |
2013-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 糖尿病 / 歯周病 / 歯髄炎 / 歯内治療学 |
Outline of Final Research Achievements |
It is said Japan has approximately 9 million diabetics (including the person that diabetes is strongly soubted and the person who can not deny possibility of diabetes)(The National Health and Mutririon Survey in Japan), and there is a person receiving an injection of insulin and/or treated for oral diabetic agents, but the thing which a patient of approximately 80% takes in medicine is medicine called the incretin now. The incretin medications have not only I a state of diabetes better but also various action (potection of heart and/or kidney). I found the finding in vitro that the action which may improve periodontal disease and pulpitis to the medicine.
|
Report
(5 results)
Research Products
(1 results)